130 related articles for article (PubMed ID: 2158394)
21. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
22. Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitive Chinese hamster ovary cell lines.
Robson CN; Hoban PR; Harris AL; Hickson ID
Cancer Res; 1987 Mar; 47(6):1560-5. PubMed ID: 2434220
[TBL] [Abstract][Full Text] [Related]
23. Isolation of two Chinese hamster ovary cell mutants hypersensitive to topoisomerase II inhibitors and cross-resistant to peroxides.
Davies SM; Davies SL; Harris AL; Hickson ID
Cancer Res; 1989 Aug; 49(16):4526-30. PubMed ID: 2545343
[TBL] [Abstract][Full Text] [Related]
24. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.
Pommier Y; Kerrigan D; Schwartz RE; Swack JA; McCurdy A
Cancer Res; 1986 Jun; 46(6):3075-81. PubMed ID: 3009009
[TBL] [Abstract][Full Text] [Related]
25. Megabase pair deletions in mutant mammalian cells following exposure to amsacrine, an inhibitor of DNA topoisomerase II.
Shibuya ML; Ueno AM; Vannais DB; Craven PA; Waldren CA
Cancer Res; 1994 Feb; 54(4):1092-7. PubMed ID: 8313366
[TBL] [Abstract][Full Text] [Related]
26. Novobiocin inhibits the repair of potentially lethal damage but not the repair of sublethal damage.
Utsumi H; Shibuya ML; Elkind MM
Radiat Res; 1990 Jul; 123(1):55-60. PubMed ID: 2164695
[TBL] [Abstract][Full Text] [Related]
27. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
Pommier Y; Kerrigan D; Covey JM; Kao-Shan CS; Whang-Peng J
Cancer Res; 1988 Feb; 48(3):512-6. PubMed ID: 2825977
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors.
Jeggo PA; Caldecott K; Pidsley S; Banks GR
Cancer Res; 1989 Dec; 49(24 Pt 1):7057-63. PubMed ID: 2479475
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells.
Jensen LH; Dejligbjerg M; Hansen LT; Grauslund M; Jensen PB; Sehested M
BMC Pharmacol; 2004 Dec; 4():31. PubMed ID: 15575955
[TBL] [Abstract][Full Text] [Related]
30. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.
Pommier Y; Schwartz RE; Zwelling LA; Kerrigan D; Mattern MR; Charcosset JY; Jacquemin-Sablon A; Kohn KW
Cancer Res; 1986 Feb; 46(2):611-6. PubMed ID: 3000581
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the effects of aphidicolin and other inhibitors on topoisomerase II-directed cytotoxic drugs.
Haldane A; Finlay GJ; Baguley BC
Oncol Res; 1993; 5(3):133-8. PubMed ID: 8260750
[TBL] [Abstract][Full Text] [Related]
32. Effect of topoisomerase II inhibitors on hyperthermic cytotoxicity.
Warters RL; Brizgys LM
Cancer Res; 1988 Jul; 48(14):3932-8. PubMed ID: 2838165
[TBL] [Abstract][Full Text] [Related]
33. Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors.
Dereuddre S; Delaporte C; Jacquemin-Sablon A
Cancer Res; 1997 Oct; 57(19):4301-8. PubMed ID: 9331091
[TBL] [Abstract][Full Text] [Related]
34. The effect of two topoisomerase inhibitors on low-dose hypersensitivity and increased radioresistance in Chinese hamster V79 cells.
Skov K; Zhou H; Marples B
Radiat Res; 1994 Apr; 138(1 Suppl):S117-20. PubMed ID: 8146313
[TBL] [Abstract][Full Text] [Related]
35. Genotoxic effects of poly-D-lysine in m-AMSA (amsacrine) treated Chinese hamster ovary (CHO) cells.
Panneerselvam N
Indian J Exp Biol; 1997 Jun; 35(6):658-60. PubMed ID: 9357173
[TBL] [Abstract][Full Text] [Related]
36. The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity.
Rene B; Fosse P; Khelifa T; Jacquemin-Sablon A; Bailly C
Mol Pharmacol; 1996 Feb; 49(2):343-50. PubMed ID: 8632768
[TBL] [Abstract][Full Text] [Related]
37. Cellular consequences of overproduction of DNA topoisomerase II in an ataxia-telangiectasia cell line.
Smith PJ; Makinson TA
Cancer Res; 1989 Mar; 49(5):1118-24. PubMed ID: 2537142
[TBL] [Abstract][Full Text] [Related]
38. Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells.
Tan KB; Mattern MR; Boyce RA; Hertzberg RP; Schein PS
NCI Monogr; 1987; (4):95-8. PubMed ID: 2819739
[TBL] [Abstract][Full Text] [Related]
39. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
40. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
Epstein RJ; Smith PJ
Cancer Res; 1988 Jan; 48(2):297-303. PubMed ID: 2825970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]